[28PO2-am1] Virus

[28PO2-am1-07] Establishment of SARS-CoV-2 respiratory tract infection model in CAG promoter-driven hACE2 transgenic mice

○DAICHI UTSUMI¹, Masamitsu Asaka¹, Haruhiko Kamada^2,3,4, Satoshi Nagata³, Yutaka Nakachi⁵, Tomokazu Yamaguchi⁶, Yoshihiro Kawaoka^7,8,9, Keiji Kuba⁶, Yasuhiro Yasutomi¹ (1. Tsukuba Primate Res. Ctr., NIBIOHN, 2. Lab. of Biopharmaceutical Res., NIBIOHN, 3. Lab. of Antibody Design., NIBIOHN, 4. Global Ctr for Med. Eng. and Informatics, Osaka Univ., 5. Dept. of Mol. Brain Sci. Grad. Sch. of Med. Sci., Kumamoto Univ., 6. Dept. of Biochem. and Metabolic Sci., Grad. Sch. of Med., Akita Univ., 7. Influenza Res. Inst., Dept. of Pathobiological Sci., Sch. of Veterinary Med., Univ. of Wisconsin, 8. Divi. of Virology, Dept. of Microbiol. and Immunol. Inst. of Med. Sci., Univ. of Tokyo, 9. Natl. Ctr. for Global Health and Med.)